# Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone

> **NCT01301677** · PHASE1 · COMPLETED · sponsor: **X-pert Med GmbH** · enrollment: 47 (estimated)

## Conditions studied

- Erythema
- Pain

## Interventions

- **DRUG:** Hydrocortisone
- **DRUG:** 2PX+
- **DRUG:** 2PX-

## Key facts

- **NCT ID:** NCT01301677
- **Lead sponsor:** X-pert Med GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2011-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301677, "Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01301677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*